Agenus Inc. (AGEN)
USD 3.11
(8.74%)
USD 3.11
(8.74%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -159.54 Million USD | 10.77% |
| 2022 | -179.42 Million USD | -524.39% |
| 2021 | 42.27 Million USD | 136.06% |
| 2020 | -117.23 Million USD | -67.15% |
| 2019 | -70.13 Million USD | 43.36% |
| 2018 | -123.82 Million USD | -19.29% |
| 2017 | -103.8 Million USD | 3.42% |
| 2016 | -107.47 Million USD | -33.18% |
| 2015 | -80.7 Million USD | -86.29% |
| 2014 | -43.32 Million USD | -73.42% |
| 2013 | -24.98 Million USD | -270.57% |
| 2012 | -6.74 Million USD | 64.68% |
| 2011 | -19.08 Million USD | 12.25% |
| 2010 | -21.75 Million USD | 21.41% |
| 2009 | -27.67 Million USD | 26.86% |
| 2008 | -37.84 Million USD | -13.72% |
| 2007 | -33.27 Million USD | 34.25% |
| 2006 | -50.61 Million USD | 31.52% |
| 2005 | -73.91 Million USD | -6.06% |
| 2004 | -69.68 Million USD | -2.88% |
| 2003 | -67.73 Million USD | -18.06% |
| 2002 | -57.37 Million USD | -37.83% |
| 2001 | -41.62 Million USD | -55.99% |
| 2000 | -26.68 Million USD | -41.94% |
| 1999 | -18.8 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -32.88 Million USD | -654.35% |
| 2024 Q2 | -30.19 Million USD | 8.18% |
| 2023 FY | -160.1 Million USD | 10.77% |
| 2023 Q3 | -46.34 Million USD | 15.23% |
| 2023 Q2 | -54.66 Million USD | -0.6% |
| 2023 Q4 | -4.35 Million USD | 90.59% |
| 2023 Q1 | -54.34 Million USD | 5.91% |
| 2022 Q3 | -41.64 Million USD | 6.55% |
| 2022 Q1 | -35.46 Million USD | 34.36% |
| 2022 FY | -179.42 Million USD | -524.39% |
| 2022 Q4 | -57.75 Million USD | -38.69% |
| 2022 Q2 | -44.56 Million USD | -25.67% |
| 2021 FY | 42.27 Million USD | 136.06% |
| 2021 Q2 | -66.39 Million USD | -60.49% |
| 2021 Q1 | -41.37 Million USD | -90.58% |
| 2021 Q4 | -54.02 Million USD | -128.81% |
| 2021 Q3 | 187.54 Million USD | 382.46% |
| 2020 Q4 | -21.7 Million USD | 37.6% |
| 2020 Q2 | -33.27 Million USD | -21.15% |
| 2020 Q1 | -27.46 Million USD | -42.48% |
| 2020 FY | -117.23 Million USD | -67.15% |
| 2020 Q3 | -34.78 Million USD | -4.55% |
| 2019 Q3 | -35.92 Million USD | 12.69% |
| 2019 Q4 | -19.27 Million USD | 46.34% |
| 2019 Q1 | 26.2 Million USD | 166.47% |
| 2019 Q2 | -41.14 Million USD | -257.0% |
| 2019 FY | -70.13 Million USD | 43.36% |
| 2018 Q3 | -26.07 Million USD | -57.35% |
| 2018 FY | -123.82 Million USD | -19.29% |
| 2018 Q1 | -41.74 Million USD | -39.2% |
| 2018 Q2 | -16.57 Million USD | 60.31% |
| 2018 Q4 | -39.42 Million USD | -51.2% |
| 2017 Q3 | -31.66 Million USD | -9.61% |
| 2017 FY | -103.8 Million USD | 3.42% |
| 2017 Q1 | -13.25 Million USD | 32.62% |
| 2017 Q2 | -28.88 Million USD | -117.9% |
| 2017 Q4 | -29.99 Million USD | 5.28% |
| 2016 Q3 | -36.22 Million USD | -53.44% |
| 2016 Q2 | -23.6 Million USD | 15.59% |
| 2016 FY | -107.47 Million USD | -33.18% |
| 2016 Q4 | -19.67 Million USD | 45.68% |
| 2016 Q1 | -27.96 Million USD | -54.12% |
| 2015 FY | -80.7 Million USD | -86.29% |
| 2015 Q2 | -33.19 Million USD | -81.47% |
| 2015 Q1 | -18.29 Million USD | -3.58% |
| 2015 Q4 | -18.14 Million USD | -63.96% |
| 2015 Q3 | -11.06 Million USD | 66.66% |
| 2014 FY | -43.32 Million USD | -73.42% |
| 2014 Q4 | -17.65 Million USD | -130.18% |
| 2014 Q2 | -8.22 Million USD | 16.33% |
| 2014 Q3 | -7.67 Million USD | 6.67% |
| 2014 Q1 | -9.82 Million USD | -57.76% |
| 2013 FY | -24.98 Million USD | -270.57% |
| 2013 Q4 | -6.22 Million USD | 8.63% |
| 2013 Q1 | -4.6 Million USD | -8.99% |
| 2013 Q3 | -6.81 Million USD | 7.01% |
| 2013 Q2 | -7.32 Million USD | -59.01% |
| 2012 Q1 | 7.8 Million USD | 258.49% |
| 2012 Q4 | -4.22 Million USD | 6.87% |
| 2012 FY | -6.74 Million USD | 64.68% |
| 2012 Q2 | -5.77 Million USD | -173.98% |
| 2012 Q3 | -4.54 Million USD | 21.31% |
| 2011 Q1 | -5.02 Million USD | -1.35% |
| 2011 Q3 | -4.44 Million USD | 5.55% |
| 2011 Q4 | -4.92 Million USD | -10.83% |
| 2011 FY | -19.08 Million USD | 12.25% |
| 2011 Q2 | -4.7 Million USD | 6.38% |
| 2010 FY | -21.75 Million USD | 21.41% |
| 2010 Q4 | -4.95 Million USD | -1.41% |
| 2010 Q3 | -4.88 Million USD | -5.12% |
| 2010 Q2 | -4.64 Million USD | 35.97% |
| 2010 Q1 | -7.26 Million USD | -39.72% |
| 2009 Q4 | -5.19 Million USD | 18.38% |
| 2009 Q3 | -6.36 Million USD | 19.69% |
| 2009 Q2 | -7.92 Million USD | 3.18% |
| 2009 Q1 | -8.18 Million USD | -19.24% |
| 2009 FY | -27.67 Million USD | 26.86% |
| 2008 Q2 | -10.98 Million USD | -8.15% |
| 2008 Q4 | -6.86 Million USD | 30.25% |
| 2008 Q1 | -10.15 Million USD | -56.69% |
| 2008 FY | -37.84 Million USD | -13.72% |
| 2008 Q3 | -9.84 Million USD | 10.36% |
| 2007 FY | -33.27 Million USD | 34.25% |
| 2007 Q4 | -6.47 Million USD | 34.21% |
| 2007 Q3 | -9.84 Million USD | -9.4% |
| 2007 Q2 | -9 Million USD | -13.33% |
| 2007 Q1 | -7.94 Million USD | 27.52% |
| 2006 Q4 | -10.96 Million USD | -1.71% |
| 2006 Q1 | -15.05 Million USD | 14.9% |
| 2006 Q2 | -13.82 Million USD | 8.18% |
| 2006 FY | -50.61 Million USD | 31.52% |
| 2006 Q3 | -10.77 Million USD | 22.04% |
| 2005 Q4 | -17.69 Million USD | -3.12% |
| 2005 Q2 | -21.08 Million USD | -17.25% |
| 2005 Q1 | -17.98 Million USD | -3.99% |
| 2005 Q3 | -17.15 Million USD | 18.64% |
| 2005 FY | -73.91 Million USD | -6.06% |
| 2004 Q4 | -17.29 Million USD | 7.74% |
| 2004 Q1 | -17.59 Million USD | 4.41% |
| 2004 Q2 | -17.04 Million USD | 3.15% |
| 2004 FY | -69.68 Million USD | -2.88% |
| 2004 Q3 | -18.74 Million USD | -9.98% |
| 2003 Q3 | -18.13 Million USD | -5.72% |
| 2003 Q1 | -14.04 Million USD | 16.5% |
| 2003 Q2 | -17.15 Million USD | -22.14% |
| 2003 FY | -67.73 Million USD | -18.06% |
| 2003 Q4 | -18.4 Million USD | -1.53% |
| 2002 FY | -57.37 Million USD | -37.83% |
| 2002 Q4 | -16.81 Million USD | -20.37% |
| 2002 Q3 | -13.97 Million USD | 3.17% |
| 2002 Q2 | -14.42 Million USD | -18.7% |
| 2002 Q1 | -12.15 Million USD | -159.35% |
| 2001 Q2 | -9.24 Million USD | -9.25% |
| 2001 Q1 | -8.45 Million USD | 0.5% |
| 2001 FY | -41.62 Million USD | -55.99% |
| 2001 Q4 | 20.48 Million USD | 146.12% |
| 2001 Q3 | -44.41 Million USD | -380.56% |
| 2000 Q3 | -6.36 Million USD | 0.41% |
| 2000 Q1 | -5.42 Million USD | 0.0% |
| 2000 Q2 | -6.39 Million USD | -17.7% |
| 2000 Q4 | -8.5 Million USD | -33.58% |
| 2000 FY | -26.68 Million USD | -41.94% |
| 1999 FY | -18.8 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | -38.12% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | 29.725% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | 43.457% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -1505.501% |
| Apollomics, Inc. | -54.83 Million USD | -190.967% |
| 180 Life Sciences Corp. | -13.47 Million USD | -1083.817% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -408.49% |
| Bicycle Therapeutics plc | -189.94 Million USD | 16.003% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -90.134% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | 7.121% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -531.127% |
| Chimerix, Inc. | -93.06 Million USD | -71.438% |
| CRISPR Therapeutics AG | -222.53 Million USD | 28.305% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 1092.405% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -116.596% |
| Fortress Biotech, Inc. | -142.34 Million USD | -12.088% |
| Fortress Biotech, Inc. | -142.34 Million USD | -12.088% |
| Gritstone bio, Inc. | -154.63 Million USD | -3.178% |
| Allakos Inc. | -196.05 Million USD | 18.621% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -191.169% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -31.321% |
| Cytokinetics, Incorporated | -496.2 Million USD | 67.846% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -512.237% |
| Innoviva, Inc. | 176.7 Million USD | 190.289% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -1974.155% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1251.301% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -25.568% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -1237199.282% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -55.57% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -79.539% |
| ImmuCell Corporation | -5.74 Million USD | -2675.693% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -18.686% |
| Incyte Corporation | 620.52 Million USD | 125.712% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -17.986% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -2341.819% |
| Mustang Bio, Inc. | -50.72 Million USD | -214.531% |
| MiMedx Group, Inc. | 37.11 Million USD | 529.866% |
| MEI Pharma, Inc. | 14.54 Million USD | 1197.16% |
| MacroGenics, Inc. | -168.24 Million USD | 5.168% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -1706.644% |
| Mereo BioPharma Group plc | -28.41 Million USD | -461.476% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -994.197% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -21.344% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -404.136% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -590.103% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -904.337% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -1224.168% |
| NextCure, Inc. | -67.63 Million USD | -135.89% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -209.768% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -1410.452% |
| Onconetix, Inc. | -36.03 Million USD | -342.766% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -282.483% |
| Opthea Limited | -191.84 Million USD | 16.833% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -169.138% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -5697.934% |
| PDS Biotechnology Corporation | -43.04 Million USD | -270.654% |
| Precigen, Inc. | -88.92 Million USD | -79.424% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -436.191% |
| Prime Medicine, Inc. | -191.29 Million USD | 16.594% |
| PureTech Health plc | -146.19 Million USD | -9.131% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | 38.554% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 103.942% |
| Replimune Group, Inc. | -234.77 Million USD | 32.041% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -1743.077% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -678.63% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -721.633% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 67.251% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -556.402% |
| Sesen Bio, Inc. | -25.9 Million USD | -515.805% |
| Sangamo Therapeutics, Inc. | -274 Million USD | 41.772% |
| Solid Biosciences Inc. | -104.31 Million USD | -52.949% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | 30.617% |
| SciSparc Ltd. | -5.77 Million USD | -2663.71% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -78.71% |
| TG Therapeutics, Inc. | 20.63 Million USD | 873.271% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -34.777% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -2092.511% |
| Travere Therapeutics, Inc. | -376.74 Million USD | 57.651% |
| UroGen Pharma Ltd. | -65.53 Million USD | -143.452% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -142.627% |
| XOMA Corporation | -41.84 Million USD | -281.258% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | 35.921% |
| AbCellera Biologics Inc. | -237.2 Million USD | 32.738% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -181.099% |
| Cassava Sciences, Inc. | -105.95 Million USD | -50.579% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -253.945% |
| Precision BioSciences, Inc. | -43.73 Million USD | -264.8% |
| Dyadic International, Inc. | -8.22 Million USD | -1838.688% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -1817.887% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -13284.983% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -445.318% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -21.614% |
| IGM Biosciences, Inc. | -263.46 Million USD | 39.441% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -48.387% |
| Acelyrin, Inc. | -422.06 Million USD | 62.198% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -238.494% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 1436.032% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -694.179% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -104.014% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -23.693% |
| Senti Biosciences, Inc. | -92.72 Million USD | -72.063% |
| Mesoblast Limited | -58.79 Million USD | -171.37% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | 3.613% |
| ChromaDex Corporation | -5.59 Million USD | -2749.598% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -3229.858% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -244.926% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -1883.97% |
| Seer, Inc. | -103.46 Million USD | -54.209% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -262.529% |
| Novavax, Inc. | -566.51 Million USD | 71.837% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -916.897% |
| Fate Therapeutics, Inc. | -190.51 Million USD | 16.252% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -205.954% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | 35.01% |
| Celcuity Inc. | -66.23 Million USD | -140.9% |
| ContextLogic Inc. | -328 Million USD | 51.357% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | 4.64% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -63.315% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 127.576% |
| Amarin Corporation plc | -67.58 Million USD | -136.061% |
| AnaptysBio, Inc. | -164.41 Million USD | 2.957% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -452.493% |
| Aptorum Group Limited | -10.52 Million USD | -1416.146% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -84.629% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | 22.172% |
| Ardelyx, Inc. | -63.27 Million USD | -152.148% |
| Celularity Inc. | -192.28 Million USD | 17.026% |
| Omeros Corporation | -164.53 Million USD | 3.027% |
| Humacyte, Inc. | -100.04 Million USD | -59.474% |
| Immunocore Holdings plc | -59.64 Million USD | -167.48% |
| IO Biotech, Inc. | -91.44 Million USD | -74.479% |
| GT Biopharma, Inc. | -13.57 Million USD | -1075.228% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -113.701% |
| Summit Therapeutics Inc. | -89.73 Million USD | -77.798% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -365.605% |
| Pulmatrix, Inc. | -14.74 Million USD | -982.422% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 69.037% |
| Evogene Ltd. | -26.39 Million USD | -504.558% |
| CorMedix Inc. | -48.95 Million USD | -225.891% |
| BioLineRx Ltd. | -49.69 Million USD | -221.063% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -383.174% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -419.027% |
| PTC Therapeutics, Inc. | -349.4 Million USD | 54.337% |
| scPharmaceuticals Inc. | -55.39 Million USD | -188.015% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -44.174% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 248.719% |
| NLS Pharmaceutics AG | -11.8 Million USD | -1251.301% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -556.402% |
| Akero Therapeutics, Inc. | -172.87 Million USD | 7.706% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -643.264% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -520.62% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -39.013% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -92.105% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -200.32% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -744.278% |
| Daré Bioscience, Inc. | -30.83 Million USD | -417.346% |
| bluebird bio, Inc. | -244.26 Million USD | 34.681% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 182.055% |
| DBV Technologies S.A. | -76.43 Million USD | -108.746% |
| Avidity Biosciences, Inc. | -235.59 Million USD | 32.279% |
| Galecto, Inc. | -39.9 Million USD | -299.822% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -330.469% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -206.866% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | 27.22% |
| GlycoMimetics, Inc. | -39.27 Million USD | -306.232% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | 33.825% |
| ADMA Biologics, Inc. | 21.63 Million USD | 837.56% |
| Clene Inc. | -40.54 Million USD | -293.559% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | 54.422% |
| Aptose Biosciences Inc. | -52.35 Million USD | -204.739% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -1006.383% |
| Soligenix, Inc. | -7.69 Million USD | -1972.619% |
| Century Therapeutics, Inc. | -146.54 Million USD | -8.873% |
| Kura Oncology, Inc. | -165.8 Million USD | 3.773% |
| Surrozen, Inc. | -45.78 Million USD | -248.512% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -70.717% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -6329.178% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -2360.657% |
| Autolus Therapeutics plc | -195.02 Million USD | 18.192% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -88.465% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -654.904% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -37.472% |
| GRI Bio, Inc. | -11.38 Million USD | -1301.15% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -3433.195% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -118.623% |
| INmune Bio, Inc. | -29.74 Million USD | -436.461% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -44.238% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -319.035% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -898.469% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -1837.699% |
| Jaguar Health, Inc. | -34.29 Million USD | -365.28% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -911.672% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -161.136% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -542.203% |
| Atara Biotherapeutics, Inc. | -276 Million USD | 42.194% |
| Coherus BioSciences, Inc. | -203.19 Million USD | 21.481% |
| Verastem, Inc. | -92.08 Million USD | -73.265% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | 13.357% |
| Histogen Inc. | -10.64 Million USD | -1399.098% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -931.214% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -117.431% |
| Surrozen, Inc. | -45.78 Million USD | -248.512% |
| Organovo Holdings, Inc. | -15.08 Million USD | -957.596% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3034.413% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -1990.296% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | 6.851% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -229.32% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -948.232% |
| Kronos Bio, Inc. | -121.83 Million USD | -30.96% |
| Turnstone Biologics Corp. | -59.03 Million USD | -170.275% |
| Synaptogenix, Inc. | -8.31 Million USD | -1819.074% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -993.85% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -4945.825% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -74.007% |
| Exelixis, Inc. | 170.88 Million USD | 193.366% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -2.893% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 69.147% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -131.697% |
| ESSA Pharma Inc. | -32.13 Million USD | -396.51% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -831.779% |
| Avid Bioservices, Inc. | -18.67 Million USD | -754.208% |
| Insmed Incorporated | -709.62 Million USD | 77.516% |
| MediWound Ltd. | -15.29 Million USD | -943.486% |
| OmniAb, Inc. | -69.41 Million USD | -129.835% |
| Alector, Inc. | -151.74 Million USD | -5.146% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -47.754% |
| Zai Lab Limited | -366.57 Million USD | 56.476% |
| AlloVir, Inc. | -181.33 Million USD | 12.012% |
| Revance Therapeutics, Inc. | -316.77 Million USD | 49.634% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -44.023% |
| Aura Biosciences, Inc. | -84.99 Million USD | -87.725% |
| Immunic, Inc. | -99.22 Million USD | -60.798% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -11.45% |
| Veracyte, Inc. | -85.79 Million USD | -85.965% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | 43.385% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1022.794% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 283.787% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -2216.351% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -748.998% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -526.838% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 511.188% |
| Fortrea Holdings Inc. | 63.1 Million USD | 352.851% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -13.602% |
| XBiotech Inc. | -37.51 Million USD | -325.351% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -131.697% |
| Keros Therapeutics, Inc. | -169.94 Million USD | 6.115% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -321.318% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -137.707% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -47.859% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -521.49% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -199.386% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 71.97% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -103.268% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -53.843% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -616.973% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -14.758% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -2738.883% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -526.69% |
| Lantern Pharma Inc. | -17.87 Million USD | -792.454% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -271.044% |
| Ainos, Inc. | -13.2 Million USD | -1108.119% |
| Pluri Inc. | -22.15 Million USD | -620.051% |
| Prothena Corporation plc | -191.03 Million USD | 16.482% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -15.583% |
| Rallybio Corporation | -78.93 Million USD | -102.135% |
| Kodiak Sciences Inc. | -277.32 Million USD | 42.468% |
| Cue Biopharma, Inc. | -52.14 Million USD | -205.948% |
| MeiraGTx Holdings plc | -137.06 Million USD | -16.407% |
| Annexon, Inc. | -143.72 Million USD | -11.011% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -146.804% |
| Moderna, Inc. | -4.23 Billion USD | 96.236% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -759.685% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -551.673% |
| Blueprint Medicines Corporation | -486.27 Million USD | 67.19% |
| Immix Biopharma, Inc. | -16.14 Million USD | -888.463% |
| CalciMedica, Inc. | -21.87 Million USD | -629.367% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -11.331% |
| Scholar Rock Holding Corporation | -171.29 Million USD | 6.857% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -134.645% |
| Sana Biotechnology, Inc. | -326.9 Million USD | 51.193% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -346.353% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -136.19% |
| Nutriband Inc. | -4.87 Million USD | -3174.865% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -265.829% |
| Vor Biopharma Inc. | -126.03 Million USD | -26.59% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 103.761% |
| Alkermes plc | 414.12 Million USD | 138.527% |
| ProKidney Corp. | -151.52 Million USD | -5.298% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -147.229% |
| Arcellx, Inc. | -89.88 Million USD | -77.513% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 73.731% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -39.743% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -319.072% |
| Atai Life Sciences N.V. | -125.47 Million USD | -27.16% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -95.432% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -95.984% |
| MediciNova, Inc. | -9.9 Million USD | -1511.563% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -26.252% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2102.967% |
| GeoVax Labs, Inc. | -26.74 Million USD | -496.602% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | 31.177% |
| Biomea Fusion, Inc. | -126.13 Million USD | -26.491% |
| RenovoRx, Inc. | -11.39 Million USD | -1300.044% |
| Cullinan Oncology, Inc. | -191.08 Million USD | 16.505% |
| Geron Corporation | -193.94 Million USD | 17.735% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -478.348% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -41.36% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | 34.115% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -533.231% |
| Royalty Pharma plc | 1.49 Billion USD | 110.693% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | 23.292% |
| Imunon, Inc. | -21.03 Million USD | -658.658% |
| BioAtla, Inc. | -129.68 Million USD | -23.026% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | 51.318% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -282.08% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | 6.673% |
| Structure Therapeutics Inc. | -102.77 Million USD | -55.241% |
| 89bio, Inc. | -151.2 Million USD | -5.519% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -51.609% |
| aTyr Pharma, Inc. | -54.91 Million USD | -190.517% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -82.494% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | 37.297% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -1842.698% |
| Akari Therapeutics, Plc | -16.8 Million USD | -849.357% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -1804134.521% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 147.263% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | 7.104% |
| Liquidia Corporation | -73.38 Million USD | -117.417% |
| Entera Bio Ltd. | -8.89 Million USD | -1694.5% |
| GH Research PLC | -41.22 Million USD | -287.048% |
| Vericel Corporation | -6.46 Million USD | -2368.27% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -104.28% |
| Xencor, Inc. | -138.63 Million USD | -15.082% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -2995.284% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -898.469% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -642.395% |
| Vaxcyte, Inc. | -468.04 Million USD | 65.911% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | 25.463% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -1043.556% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -2341.819% |
| Portage Biotech Inc. | -18.25 Million USD | -774.097% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -2102.967% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -52.008% |
| OncoCyte Corporation | -25.13 Million USD | -534.743% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -1311.331% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -1292.582% |
| Purple Biotech Ltd. | 22.27 Million USD | 816.398% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -447.207% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -444.443% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | 13.457% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -2023.922% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -438.453% |
| United Therapeutics Corporation | 1.18 Billion USD | 113.465% |
| HilleVax, Inc. | -133.34 Million USD | -19.651% |
| Silo Pharma, Inc. | -3.85 Million USD | -4038.119% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -3947.363% |
| Pharming Group N.V. | -4.87 Million USD | -3169.752% |
| Tharimmune, Inc. | -9.45 Million USD | -1587.417% |
| Genprex, Inc. | -31.07 Million USD | -413.423% |
| Apogee Therapeutics, Inc. | -93 Million USD | -71.553% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | 15.221% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -94.108% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -20756.078% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -2829.161% |
| OKYO Pharma Limited | -15.74 Thousand USD | -1012926.89% |
| Savara Inc. | -60 Million USD | -165.884% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -809.681% |
| Curis, Inc. | -48.33 Million USD | -230.11% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -2958.088% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -485.501% |
| BeiGene, Ltd. | -1.2 Billion USD | 86.789% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -70.364% |
| Erasca, Inc. | -141.52 Million USD | -12.736% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -3424.407% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -3424.407% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -274.449% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -2408.632% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -137.293% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -3.24% |
| Cogent Biosciences, Inc. | -208.13 Million USD | 23.342% |
| Adicet Bio, Inc. | -152.03 Million USD | -4.94% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -117.091% |
| Aditxt, Inc. | -26.06 Million USD | -512.18% |
| Adagene Inc. | -23.71 Million USD | -572.639% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2082.584% |
| Quantum-Si incorporated | -111.17 Million USD | -43.517% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -994.468% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 230.763% |
| Compugen Ltd. | -12.99 Million USD | -1128.056% |
| Generation Bio Co. | -138.56 Million USD | -15.145% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -92.158% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -84.535% |
| Invivyd, Inc. | -207.78 Million USD | 23.214% |
| Relay Therapeutics, Inc. | -373 Million USD | 57.225% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -1601.22% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 842.745% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -1450.977% |
| 2seventy bio, Inc. | -216.7 Million USD | 26.374% |
| Instil Bio, Inc. | -159.16 Million USD | -0.239% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -562.638% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -4248.484% |
| GeoVax Labs, Inc. | -26.74 Million USD | -496.602% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -334.359% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -53.853% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | 6.301% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 76.685% |
| Evaxion Biotech A/S | -22.19 Million USD | -618.786% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -93.67% |
| Verve Therapeutics, Inc. | -223.12 Million USD | 28.493% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -99.573% |
| Cingulate Inc. | -22.75 Million USD | -601.031% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 2229.592% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -257.197% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -157.03% |
| Clearmind Medicine Inc. | -8.74 Million USD | -1725.221% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -109.393% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -5339.816% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -58.24% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | 58.068% |
| ImmunityBio, Inc. | -362.25 Million USD | 55.956% |
| Korro Bio, Inc. | -84.53 Million USD | -88.739% |
| Kineta, Inc. | -15.72 Million USD | -914.749% |
| BioVie Inc. | -32.17 Million USD | -395.808% |
| Codexis, Inc. | -68.06 Million USD | -134.393% |
| Celularity Inc. | -192.28 Million USD | 17.026% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -880.272% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | 28.327% |
| Virax Biolabs Group Limited | -6.49 Million USD | -2355.933% |
| Cibus, Inc. | -318.88 Million USD | 49.966% |
| IN8bio, Inc. | -30.33 Million USD | -425.922% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -28.886% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -580.554% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | 54.895% |
| Eyenovia, Inc. | -25.4 Million USD | -527.986% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 588.814% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -2768.554% |
| Elevation Oncology, Inc. | -45.44 Million USD | -251.082% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -101.621% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -251.337% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -16.283% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -412.871% |
| Moolec Science SA | -6.65 Million USD | -2297.861% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -160.965% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -268.874% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | 2.81% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -216.798% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -1610.456% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -628.712% |
| Humacyte, Inc. | -100.04 Million USD | -59.474% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -99.108% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -997.311% |
| Genelux Corporation | -24.16 Million USD | -560.248% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -370.327% |
| Notable Labs, Ltd. | -14.65 Million USD | -988.552% |
| Immunovant, Inc. | -282.7 Million USD | 43.564% |
| Quantum-Si incorporated | -111.17 Million USD | -43.517% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -650.219% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -56.402% |
| Acasti Pharma Inc. | -11.31 Million USD | -1310.44% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -596.079% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -285.533% |
| PepGen Inc. | -84.76 Million USD | -88.223% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -596.812% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -386.31% |
| Immuneering Corporation | -58.41 Million USD | -173.14% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -3034.413% |
| Belite Bio, Inc | -31.66 Million USD | -403.818% |
| XOMA Corporation | -41.84 Million USD | -281.258% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -136.299% |
| Bionomics Limited | -17.89 Billion USD | 99.108% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 547.166% |
| uniQure N.V. | -282.87 Million USD | 43.597% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -2082.584% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -23.2% |
| Forte Biosciences, Inc. | -32.48 Million USD | -391.132% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -1820.252% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -442.776% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -2768.554% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -1022.794% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -1694.904% |
| Altimmune, Inc. | -95.92 Million USD | -66.32% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -118.231% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 547.166% |
| Peak Bio, Inc. | -1356.23 USD | -11764055.047% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -221.645% |
| Benitec Biopharma Inc. | -22.49 Million USD | -609.422% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | 34.153% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -436.371% |
| Zura Bio Limited | -62.63 Million USD | -154.716% |
| PolyPid Ltd. | -22.86 Million USD | -597.726% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -436.371% |
| argenx SE | -425.04 Million USD | 62.463% |
| Immunome, Inc. | -109.53 Million USD | -45.667% |
| Verona Pharma plc | -67.83 Million USD | -135.216% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -512.237% |
| Shattuck Labs, Inc. | -91.95 Million USD | -73.504% |
| CervoMed Inc. | -7.81 Million USD | -1942.124% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -1097.725% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -231.193% |
| Moolec Science SA | -6.65 Million USD | -2297.861% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -869.995% |
| Design Therapeutics, Inc. | -78.19 Million USD | -104.053% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -83.303% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -293.958% |
| Achilles Therapeutics plc | -75.25 Million USD | -112.011% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -5339.816% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -187.74% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -213.85% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -141.379% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -194.789% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -251.36% |
| Beam Therapeutics Inc. | -176.48 Million USD | 9.596% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -46.169% |
| AEON Biopharma, Inc. | -48.42 Million USD | -229.449% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -121.802% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -91.01% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -1167.58% |
| NeurAxis, Inc. | -6.66 Million USD | -2294.015% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 65.358% |
| Lumos Pharma, Inc. | -36.61 Million USD | -335.76% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 3194.247% |
| Palisade Bio, Inc. | -13.07 Million USD | -1120.727% |
| Nutriband Inc. | -4.87 Million USD | -3174.865% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -120.253% |
| Neurogene Inc. | -55.58 Million USD | -187.046% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -1776.826% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -64.977% |
| Athira Pharma, Inc. | -125.46 Million USD | -27.165% |
| HCW Biologics Inc. | -25.71 Million USD | -520.399% |
| XOMA Corporation | -41.84 Million USD | -281.258% |
| Nektar Therapeutics | -137.42 Million USD | -16.099% |
| Arvinas, Inc. | -401.5 Million USD | 60.262% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -1804134.521% |
| Merus N.V. | -156.54 Million USD | -1.918% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -59.134% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -360.858% |
| Rezolute, Inc. | -70.42 Million USD | -126.558% |
| Clene Inc. | -40.54 Million USD | -293.559% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -874.138% |
| BeyondSpring Inc. | -23.11 Million USD | -590.27% |
| Synlogic, Inc. | -55.16 Million USD | -189.242% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -789.893% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -1374.03% |
| Peak Bio, Inc. | -1356.23 USD | -11764055.047% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -293.919% |
| Krystal Biotech, Inc. | -109.72 Million USD | -45.405% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -23.166% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | 53.486% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -3261.791% |
| MannKind Corporation | 8.67 Million USD | 1938.546% |
| Ikena Oncology, Inc. | -75.41 Million USD | -111.556% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -1553.872% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -137.318% |
| Gossamer Bio, Inc. | -183.75 Million USD | 13.175% |
| CohBar, Inc. | -12.38 Million USD | -1187.901% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -214.543% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -478.348% |
| Legend Biotech Corporation | -439.48 Million USD | 63.696% |
| Mural Oncology plc | -194.63 Million USD | 18.028% |
| Disc Medicine, Inc. | -91.12 Million USD | -75.088% |
| Champions Oncology, Inc. | -7.35 Million USD | -2068.964% |
| REGENXBIO Inc. | -268.12 Million USD | 40.495% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -1388.582% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -186.156% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -309.513% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -39.518% |
| Vaxart, Inc. | -83.34 Million USD | -91.427% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -1772.639% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -272.83% |
| Cellectis S.A. | -106.62 Million USD | -49.634% |
| Longeveron Inc. | -21.02 Million USD | -658.709% |
| Repare Therapeutics Inc. | -116.22 Million USD | -37.277% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | 40.428% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -110.918% |
| Revolution Medicines, Inc. | -487.18 Million USD | 67.251% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -2298.512% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -262.991% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -113.901% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -129.122% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -1348.996% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 103.704% |
| Denali Therapeutics Inc. | -196.69 Million USD | 18.887% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -1743.077% |
| Veru Inc. | -93.78 Million USD | -70.127% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -583.908% |
| Cingulate Inc. | -22.75 Million USD | -601.031% |
| Passage Bio, Inc. | -108.38 Million USD | -47.2% |
| Context Therapeutics Inc. | -25.07 Million USD | -536.348% |
| Exicure, Inc. | -14.99 Million USD | -963.944% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | 22.573% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -292.997% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -1541.968% |
| Nuvalent, Inc. | -149.49 Million USD | -6.727% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -1841.81% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -79.812% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -668.023% |
| OmniAb, Inc. | -69.41 Million USD | -129.835% |
| Anew Medical, Inc. | -1.3 Million USD | -12165.075% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -1149.307% |
| Lipocine Inc. | -17.93 Million USD | -789.796% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -132.874% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -109.514% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -319.035% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -303.646% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -612.781% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 72.484% |
| Ocugen, Inc. | -65.53 Million USD | -143.471% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -69.975% |
| Q32 Bio Inc. | -92.1 Million USD | -73.231% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -644.2% |
| Alumis Inc. Common Stock | -158.17 Million USD | -0.869% |
| Equillium, Inc. | -14.52 Million USD | -998.671% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -155.663% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -1918.752% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -745.736% |
| Dominari Holdings Inc. | -21.79 Million USD | -632.01% |
| Edesa Biotech, Inc. | -9.22 Million USD | -1629.949% |
| vTv Therapeutics Inc. | -25.5 Million USD | -525.633% |
| Bio-Techne Corporation | 206.68 Million USD | 177.194% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | 59.245% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 183.085% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -20.617% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -315.59% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -5.591% |
| Nkarta, Inc. | -131.65 Million USD | -21.192% |
| BioCardia, Inc. | -11.64 Million USD | -1270.225% |
| Iterum Therapeutics plc | -47.46 Million USD | -236.119% |